CF PHARMTECH (02652) spent HK$366,900 on May 14 to repurchase 17,500 shares.
Chang Feng Pharmaceuticals (02652) announced that on May 14, 2026, the company spent HK$366,900 to repurchase 17,500 shares at a repurchase price of HK$20.68-21.42 per share.
CF PHARMTECH (02652) announced that the company repurchased 17,500 shares at a total cost of 366,900 Hong Kong dollars on May 14, 2026, with a repurchase price of 20.68-21.42 Hong Kong dollars per share.
Related Articles
William Li: Chinese car companies are transitioning from single-point competition to system competition.
New stock news | Meedu once again submits application to the Hong Kong Stock Exchange to develop and provide comprehensive technology-driven marketing, sales, and operational support services.
New Stock News | Lanna Cheng submits again to the Hong Kong Stock Exchange, dedicated to the discovery, development, and commercialization of radiopharmaceuticals for cancer diagnosis and treatment.
William Li: Chinese car companies are transitioning from single-point competition to system competition.
New stock news | Meedu once again submits application to the Hong Kong Stock Exchange to develop and provide comprehensive technology-driven marketing, sales, and operational support services.
New Stock News | Lanna Cheng submits again to the Hong Kong Stock Exchange, dedicated to the discovery, development, and commercialization of radiopharmaceuticals for cancer diagnosis and treatment.
RECOMMEND
